Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRS Group Regulatory News (RS1)

Share Price Information for RS Group (RS1)

Share Price is delayed by 15 minutes
Get Live Data
620.00    0.00 (0.00%)
Bid:
619.50
Ask:
620.50
Spread: 1.00 (0.161%)
Market Cap: £2.87b
RS1 Live PriceLast checked at - London Stock Exchange

Intraday RS Group Share Chart

Trading Statement

10 Jan 2023 07:00

RNS Number : 1477M
RS Group PLC
10 January 2023
 

 

10 January 2023, 7.00am

 

RS Group plc today issues a trading update for the third quarter ended 31 December 2022

 

ONGOING GROWTH FROM PROFITABLE MARKET SHARE GAINS

 

DAVID EGAN, ACTING CHIEF EXECUTIVE OFFICER, COMMENTED: "Our differentiated proposition continues to resonate as we grow market share with our core industrial customer base, prioritising our efforts on where we can add greatest value. We have continued to outperform thanks to the strength of our high-performing people who are focused fully on delivering our strategy. Tight control of our pricing, costs and inventory indicates that our full year adjusted profit will be towards the top end of consensus estimates1. We are delighted to welcome Risoul into our Group as we continue to accelerate our growth opportunities both organically and inorganically. We are mindful of the more challenging economic backdrop but believe that this also presents opportunities to drive further profitable market share growth as we continue our Journey to Greatness."

 

 

Like-for-like revenue growth2

Region

Q1 toJun 2022

Q2 toSep 2022

Q3 toDec 2022

9 months toDec 2022

EMEA

16%

14%

12%

14%

Americas

24%

19%

6%

16%

Asia Pacific

13%

6%

(8)%

3%

Group

18%

15%

8%

14%

 

Q3 revenue performance remains solid

· Like-for-like revenue growth of 8% despite a tougher economic backdrop and strong comparatives.

· Industrial products, c. 77% of Group revenue, grew like-for-like revenue by 15% with low single digit volume growth.

· Electronics products' like-for-like revenue fell 4%, reflecting the slower market.

· EMEA's growth remained strong as our differentiated proposition resonates with customers, with UK and Ireland performing the best within the region. We continue to focus on developing our service solutions offer and working more closely with strategic suppliers to broaden our range while improving our customer service levels further.

· Americas is trading against very strong comparative growth (of 37%). Our revenue per day remains strong due to investment in our people, product range, digital and operational capabilities. Our strengthened proposition, deeper relationships with customers and suppliers and improved sales initiatives are delivering market share growth.

· Asia Pacific's performance continues to be affected by greater exposure to electronics (c. 35% of region's revenue), low availability of single-board computing (SBC) product, a challenging geopolitical backdrop and tough comparatives. Like-for-like revenue excluding SBC was down 2% with industrial products' like-for-like revenue growing 10%. We continue to focus on profitable revenue growth and developing our industrial product and service solutions, helped by our acquisition of domnick hunter.

· RS PRO like-for-like revenue grew 19% due to greater brand equity, focused campaigns and better marketing tools.

· Web like-for-like revenue increased by 9%, with digital participation of 64%.

Inflationary cost headwinds are being offset by margin optimisation and tight cost control as we continue to invest

· Our gross margin continues to benefit from margin optimisation work and an improved pricing and discount model.

· Our inventory turn has increased from H1 as our purchases reflect faster-turning lines and customer demand.

· Despite inflationary pressures, we are managing costs tightly while continuing to invest in growth opportunities.

Our performance leads us to expect full year profit to be towards the top end of consensus estimates

On 3 January 2023 Risoul became part of RS Group and our teams are now working closely together in developing product and service solutions further across Americas, including our own brand, RS PRO. We continue to deliver profitable market share growth, focusing our proposition where we can generate the greatest value and drive future opportunities. Given our performance year to date we expect our full year adjusted profit before tax to be towards the top end of current consensus estimates1. We continue to be mindful of a more challenging backdrop but remain confident in the strength of our people and differentiated proposition. We are focused on driving further market share gains to generate stronger revenue and high-quality, profitable growth.

 

 

Notes:

1. Consensus for the year ending 31 March 2023 is revenue of £2,930 million (range of £2,709 million - £3,043 million), adjusted operating profit of £373.5 million (£356.8 million - £384.1 million) and adjusted profit before tax of £365.5 million (£350.4 million - £374.9 million). Source: rsgroup.com/investors/analyst-coverage.

2. Like-for-like revenue growth is growth in revenue adjusted to eliminate the impact of acquisitions and the effects of changes in exchange rates and trading days year on year. Acquisitions are only included once they have been owned for a year, at which point they start to be included in both the current and comparative periods for the same number of months. 2021/22 is converted at 2022/23 average exchange rates for the period.  

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. Average exchange rates for the year ended 31 March 2022 for euro and US dollar were €1.176 and $1.366 respectively. Average exchange rates for the half year ended 30 September 2022 for euro and US dollar were €1.174 and $1.216 respectively. Every 1 cent movement in the euro has a c. £1.8 million impact on annual adjusted profit before tax. Every 1 cent movement in the US dollar has a c. £0.7 million impact on annual adjusted profit before tax. 

4. We expect to see a negative impact of around £10 million on revenue from fewer trading days in 2022/23 compared to 2021/22.  

 

Enquiries:

David Egan

Acting Chief Executive Officer

020 7239 8400

Lucy Sharma

VP Investor Relations

020 7239 8427

Martin Robinson / Olivia Peters

Tulchan Communications

020 7353 4200

 

Conference call details

There will be a conference call for analysts and investors today at 8.00am UK time. A recording of the conference will be provided shortly after the event via the investor relations page of the RS Group website: www.rsgroup.com/investors  

Please find the registration link below to join digitally. It is advisable to pre-register early to avoid any delays in joining the conference call. To ask a question, participants will need to be connected by phone.

Pre-registration link: https://webcast.openbriefing.com/rsgroup-jan23/

Participant dial in number:

United Kingdom: 020 3936 2999

All other locations: +44 20 3936 2999

Access code: 039451

Conference call timing

Date: Tuesday, 10 January 2023

Time: 8.00am UK time

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKFNESSDEFA
Date   Source Headline
2nd Sep 202411:00 amRNSTotal Voting Rights
6th Aug 202410:00 amRNSDirector/PDMR Shareholding
1st Aug 20244:06 pmRNSTotal Voting Rights
1st Aug 20242:00 pmRNSBlock listing Interim Review
24th Jul 202411:00 amRNSDirector/PDMR Shareholding
17th Jul 202411:30 amRNSDirectorate Change
11th Jul 20243:14 pmRNSResult of AGM
11th Jul 20247:00 amRNSAGM Update
2nd Jul 20242:00 pmRNSDirector/PDMR Shareholding
2nd Jul 20242:00 pmRNSDirector/PDMR Shareholding
7th Jun 202410:00 amRNSDirector/PDMR Shareholding
6th Jun 202412:00 pmRNSAnnual Financial Report
3rd Jun 20241:03 pmRNSTotal Voting Rights
30th May 20245:26 pmRNSDirector/PDMR Shareholding
23rd May 202410:00 amRNSDirector/PDMR Shareholding
22nd May 20247:00 amRNSFinal Results
10th May 20245:28 pmRNSHolding(s) in Company
1st May 20249:40 amRNSTotal Voting Rights
26th Apr 20243:00 pmRNSDirector Declaration
2nd Apr 202410:00 amRNSTotal Voting Rights
19th Mar 202410:00 amRNSBlock Listing Application
1st Mar 20249:27 amRNSTotal Voting Rights
1st Feb 20241:18 pmRNSBlock listing Interim Review
1st Feb 202410:21 amRNSTotal Voting Rights
25th Jan 20247:00 amRNSTrading Statement
10th Jan 202411:00 amRNSDirector/PDMR Shareholding
2nd Jan 202410:56 amRNSTotal Voting Rights
18th Dec 20234:00 pmRNSDirector Declaration
8th Dec 20239:00 amRNSDirector/PDMR Shareholding
1st Dec 20239:21 amRNSTotal Voting Rights
17th Nov 20232:24 pmRNSHolding(s) in Company
16th Nov 20238:00 amRNSDirector/PDMR Shareholding
14th Nov 20234:00 pmRNSDirector/PDMR Shareholding
8th Nov 20238:00 amRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSHalf-year Report
1st Nov 202312:24 pmRNSTotal Voting Rights
2nd Oct 20239:50 amRNSTotal Voting Rights
1st Sep 20239:41 amRNSTotal Voting Rights
21st Aug 20238:00 amRNSDirector/PDMR Shareholding
1st Aug 20232:44 pmRNSBlock listing Interim Review
28th Jul 20239:00 amRNSDirector/PDMR Shareholding
27th Jul 20239:00 amRNSHolding(s) in Company
27th Jul 20237:00 amRNSAppointment of Kate Ringrose as CFO
27th Jul 20237:00 amRNSQ1 Trading Update
26th Jul 20234:53 pmRNSDirector/PDMR Shareholding
25th Jul 20239:24 amRNSHolding(s) in Company
25th Jul 20238:15 amRNSHolding(s) in Company
14th Jul 202311:56 amRNSHolding(s) in Company
13th Jul 20232:35 pmRNSResult of AGM
3rd Jul 202310:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.